Vor Biopharma Inc. (VOR) Misses Q1 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St set for higher open as Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts VOR Hot Sheet
Join SI Premium – FREE
Vor Biopharma Inc. (NASDAQ: VOR) reported Q1 EPS of ($0.45), $0.06 worse than the analyst estimate of ($0.39).
For earnings history and earnings-related data on Vor Biopharma Inc. (VOR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CPS Technologies (CPSH) Reports In-Line Q3 EPS
- Peabody Energy (BTU) Misses Q3 EPS by 28c
- Vor Biopharma (VOR) Reiterated at Buy by Stifel After Earnings, Corporate Update
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
